Results 111 to 120 of about 4,182 (143)

The influence of SARS-CoV-2 vaccination on in vitro fertilization outcomes. [PDF]

Hum Vaccin Immunother
Heusler AA, Weintraub A, Stein D, Melamed-Yekel Y, Kalfon S, Pasternak Y, Kulak D.   +6 more
europepmc   +1 more source

Safety and Immunogenicity of a Fourth Dose of Omicron BA.1-Adapted BNT162b2 COVID-19 Vaccines in Adults 18-55 Years Old. [PDF]

Clin Infect Dis
Winokur P, Diya O, Fitz-Patrick D, Dever M, Gayed J, Lockhart S, Xu X, Zhang Y, Bangad V, Wadsworth LT, Cannon K, Cardona JF, Usdan L, Ginis J, Mensa FJ, Zou J, Xie X, Lu C, Buitrago S, Scully IL, Cooper D, Koury K, Jansen KU, Türeci Ö, Şahin U, Swanson KA, Gruber WC, Kitchin N.   +27 more
europepmc   +1 more source

Unraveling COVID-19-vaccination-induced bullous pemphigoid: a case report and review of the literature. [PDF]

J Med Case Rep
Chandrasekaran S, Kamboj M, Baddepudi S, Raj R, Suresh C, Sanker V, Dave T, Wijenaike N.   +7 more
europepmc   +1 more source

GP Consultations for Venous Thromboembolism (VTE) After mRNA and Adeno-Vector-Based COVID-19 Vaccination-An Exposure-Anchored Self-Controlled Cohort Study Based on Primary Healthcare Data From the Netherlands. [PDF]

Pharmacoepidemiol Drug Saf
Jajou R, van Puijenbroek EP, Hek K, Overbeek JA, van Hunsel FPAM, Mulder E, Kant AC.   +6 more
europepmc   +1 more source

Signatures of Trained Immunity Following mRNA Vaccination: Differences Between mRNA-1273 and BNT162b2. [PDF]

J Clin Immunol
Kunc M, Whitehead BJ, Østergaard LJ, Tolstrup M, Benn CS, Wejse CM, Nejsum P.   +6 more
europepmc   +1 more source

Safety of BNT162b2 mRNA COVID-19 Vaccine Batches: A Nationwide Cohort Study. [PDF]

Pharmacoepidemiol Drug Saf
Hviid A, Svalgaard IB.
europepmc   +1 more source

Immunosenescence and cytomegalovirus-associated immune signatures on severe acute respiratory syndrome coronavirus 2 booster responses. [PDF]

J Gerontol A Biol Sci Med Sci
Reina-Alfonso I, Álvarez-Heredia P, Vallejo-Bermúdez IM, Navas-Romo A, Espinar-García M, Hassouneh F, Pérez AB, Tarazona R, Solana R, Batista-Duharte A, Molina J, Pera A.   +11 more
europepmc   +1 more source

Safety and immunogenicity of rVSVΔG-ZEBOV-GP vaccination when dosed concurrent with mRNA COVID-19 vaccine booster doses in healthy African adults (EbolaCov): protocol for a phase IV, single-centre, single-blinded, randomised controlled trial. [PDF]

BMJ Open
Gokani K, Taylor A, Packham A, Musabyimana JP, Shema H, Mutabaruka A, Roche S, Takwoingi Y, Umuhoza C, Nyombayire J, Muvunyi C, Green C.   +11 more
europepmc   +1 more source

Post coronavirus-disease-vaccination immune reconstitution inflammatory syndrome in tuberculosis treatment: a case report. [PDF]

J Med Case Rep
Mehta A, Pant A.
europepmc   +1 more source